Literature DB >> 24307974

A case of paranoid schizophrenia and severe antipsychotic-induced Parkinson's disorder treated with a combination of olanzapine and lurasidone.

Oleg V Tcheremissine1, Danielle Englert.   

Abstract

Entities:  

Year:  2013        PMID： 24307974      PMCID： PMC3849874     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN： 2158-8333


× No keyword cloud information.
  5 in total

Review 1.  New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?

Authors:  Nobumi Miyake; Seiya Miyamoto; L Fredrik Jarskog
Journal:  Clin Schizophr Relat Psychoses       Date:  2012-10

2.  Another view of the history of antipsychotic drug discovery and development.

Authors:  W T Carpenter; J M Davis
Journal:  Mol Psychiatry       Date:  2012-08-14       Impact factor: 15.992

3.  Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.

Authors:  Henry A Nasrallah; Robert Silva; Debra Phillips; Josephine Cucchiaro; Jay Hsu; Jane Xu; Antony Loebel
Journal:  J Psychiatr Res       Date:  2013-02-17       Impact factor: 4.791

Review 4.  Polypharmacy for schizophrenia.

Authors:  Jacob Ballon; T Scott Stroup
Journal:  Curr Opin Psychiatry       Date:  2013-03       Impact factor: 4.741

5.  Schizophrenia: from epidemiology to rehabilitation.

Authors:  Gioia Mura; Donatella Rita Petretto; Krishna M Bhat; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.